A case report of a novel NTRK gene fusion in pleomorphic xanthoastrocytoma
- 16 May 2022
- journal article
- letter
- Published by Dustri-Verlgag Dr. Karl Feistle in Clinical Neuropathology
- Vol. 41 (5), 233-235
- https://doi.org/10.5414/np301455
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trialVirchows Archiv A Pathological Anatomy and Histopathology, 2020
- TPM3-NTRK1 fusion in a pleomorphic xanthoastrocytoma presenting with haemorrhage in a childBMJ Case Reports, 2020
- Pleomorphic xanthoastrocytoma: a brief reviewCNS Oncology, 2019
- Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor TherapyThe Journal of Molecular Diagnostics, 2019
- Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendationsNeuro-Oncology, 2019
- Molecular features of pleomorphic xanthoastrocytomaHuman Pathology, 2018
- BRAF activating mutations involving the β3-αC loop in V600E-negative anaplastic pleomorphic xanthoastrocytomaActa Neuropathologica Communications, 2018
- Recurrent copy number alterations in low‐grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutationBrain Pathology, 2017
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomasNature Genetics, 2013
- BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic ImplicationsPLOS ONE, 2011